Skip to main content
News

Genetic testing for all breast cancer patients at point of diagnosis could save lives

A lifetime model evaluating the financial, health and social impact of multigene testing (BRCA1/2/PALB2) at diagnosis for all breast cancer patients was found to be extremely cost effective for both UK and US health systems.

Published on:
Back to top